期刊文献+

联合检测血清NTx和BSP对乳腺癌和肺癌骨转移的意义 被引量:21

Combined examination of serum cross-linked N-telopeptides of type Ⅰ collagen and bone sialoprotein in detection of bone metastasis of breast cancer and lung cancer
下载PDF
导出
摘要 目的:探讨骨代谢生化指标血清Ⅰ型胶原交联氨基末端肽(N-telopeptide of typeⅠcollagen,NTx)和骨涎酸蛋白(bone sialoprotein,BSP)的检测对肺癌和乳腺癌骨转移的临床意义。方法:选择2006年1月至2006年7月长海医院肿瘤科经病理确诊的肺癌或乳腺癌患者105例,分为两组,其中骨转移组50例,无骨转移组55例。应用ELISA法检测患者血清NTx和BSP浓度。结果:骨转移组患者血清NTx和BSP水平均明显高于无骨转移组(P<0.01)。NTx诊断骨转移的灵敏度和特异度分别为90.0%和67.3%,BSP诊断骨转移的灵敏度和特异度分别为84.0%和70.9%。临床发生骨相关事件(skeletal related event,SRE)的骨转移患者,血清NTx水平明显高于未发生SRE的骨转移患者(P<0.05)。在6~13个月随访期内,21例患者确诊了新发骨转移;采用Cox比例风险回归模型分析,血清NTx浓度升高提示骨转移发生的相对危险度为1.127;乳腺癌患者血清BSP增高是唯一预测骨转移的危险因素(P<0.05),其相对危险度为1.058。随访期共有33例患者死亡;无论肺癌还是乳腺癌,血清BSP增高患者的累积生存率均明显低于血清BSP正常组(P<0.05)。结论:血清NTx和BSP是诊断肺癌和乳腺癌骨转移的重要参考指标,其水平的增高是预测骨转移发生的高危因素;BSP可能是肺癌和乳腺癌患者独立预后指标。 Objective: To study the clinical significance of examining serum pyridinoline cross-linked N-telopeptides of type Ⅰ collagen (NTx) and serum bone sialoprotein (BSP) in diagnosing bone metastasis of lung cancer and breast cancer. Methods:A total of 105 patients treated in the Oneology Department of Changhai Hospital were included in this study. Patients were divided into 2 groups : bone metastasis ( n = 50) and non-bone metastasis groups ( n = 55). The levels of serum NTx and serum BSP were measured by ELISA. Results: The levels of serum NTx and serum BSP in patients with bone metastasis were significantly higher than in those without bone metastasis (P 〈 0. 01 ). The sensitivity and specificity of serum NTx in the diagnosis of bone metastasis were 90.0% and 67.3% , respectively; the sensitivity and specificity of serum BSP were 84.0% and 70.9% , respectively. Thirty-two patients with bone metastases had skeletal related events (SRE) and they also had significantly higher levels of serum NTx (P 〈 0.05). During the follow-up, 21 patients were diagnosed with new-onset of bone metastasis. COX anlysis showed that the relative risk ratio for bone metastasis of higher serum NTx level was 1. 127. Further analysis showed that serum BSP was the only risk factor for patients with breast cancer to develop bone metastasis (P 〈 0.01 ), with the relative risk ratio being 1. 058. During the follow-up 33 patients died. The cumulative survival rate of patients with higher serum BSP was lower than that with normal serum BSP level. Conclusion : The serum NTx and BSP were important biomarkers for diagnosis of bone metastasis. The two markers can be regarded as risk factors for bone metastasis. BSP might be an independent factor for predicting the prognosis of lung and breast cancer.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第5期478-483,共6页 Chinese Journal of Cancer Biotherapy
基金 上海市科委科技基金资助项目( No.06DZ19505)~~
关键词 Ⅰ型胶原交联氨基末端肽 骨涎酸蛋白 肺癌 乳腺癌 骨转移 诊断 预后 N-telopeptides of type Ⅰ collagen bone sialoprotein lung neoplasms breast neoplasms bone metastasis diagnosis prognosis
  • 相关文献

参考文献16

  • 1Demers LM. Bone markers in the management of patients with skeletal metastases [J]. Cancer, 2003,97 ( 3 Suppl) : 874-879.
  • 2Clines GA, Guise TA. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone[ J]. Endoer Relat Cancer, 2005,12 (3):549- 583.
  • 3Detry C, Waltregny D, Quartresooz P, et al. Detection of bone sialoprotein in human (pre)neoplastic lesions of the uterine cervix [J]. Calcif Tissue Int, 2003,73( 1 ) :9-14.
  • 4Bellahcene A, Merville MP, Castronovo V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer[ J]. Cancer Res, 1994,54( 11 ) :2823-2826.
  • 5Zhang JH, Tang J,Wang J, et al. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model[J]. Int J Oncol, 2003,23(4) : 1043-1048.
  • 6Zhang JH, Wang J,Tang J,et al. Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells [J]. Anticancer Res, 2004,24(3a) : 1361-1368.
  • 7Wahregny D, Bellahcene A,de Leval X, et al. Increased expression of bone sialoprotein in bone metastases compared with vesveral metastases in human breast and prostate cancers [ J ]. J Bone Miner Res,2000,15 ( 5 ) : 834-843.
  • 8Beke D, Kudlacek S, Meran JG. Clinical relevance of biomarkers in cancer related bone disease [ J ]. Wien Med Wochenschr, 2007, 157(15-16) : 375-380.
  • 9Demers LM, Costa L, Lipton A. Biochemical markers and skeletal metastases [ J ]. Clin Orthop Relat Res, 2003, (415 Suppl) : S138-S147.
  • 10Jae Ho Chung, Moo Suk Park, Young Sam Kim, et al. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer[J]. Yonsei Med J, 2005, 46(3) : 388-393.

同被引文献233

引证文献21

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部